Metabolic reprogramming and circadian disruption drive cellular senescence. Discover how repurposing vutiglabridin to target ...

Editas Medicine, Inc. (Nasdaq: EDIT), a pioneering gene editing company developing transformative medicines for serious diseases, shared new preclinical data supporting the continued advancement of ...

Products sweetened with dates may appear healthier than table sugar, even though concentrated fructose exposure remains a ...

Q1 total revenue of $179.1M includes estimated license revenue from Genevant related to litigation settlement with Moderna Strong financial ...

The liver is often called a "silent organ," as it can sustain significant damage without obvious symptoms. But when injury is prolonged, whether from alcohol, poor diet, or chronic hepatitis virus ...

The liver is often called a "silent organ," as it can sustain significant damage without obvious symptoms. But when injury is ...

HepaRegeniX GmbH (“HepaRegeniX”), a clinical-stage biotech company advancing novel therapies for acute and chronic liver diseases, announces that its abstract highlighting clinical data for the lead ...

Multi-echo T2* MRI identifies neonatal haemochromatosis through thyroid and pancreatic iron patterns in neonatal liver ...

Platform data establish Modified DNA’s potential to overcome two of the barriers that have kept DNA from becoming a practical ...

Bank of America Global Healthcare Conference 2026 May 13, 2026 7:35 PM EDTCompany ParticipantsAnuj Gaggar - Chief ...